Thomas Schmidt
Overview
Explore the profile of Thomas Schmidt including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
651
Citations
9360
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Grothey B, Lyu S, Quaas A, Simon A, Jung J, Schroder W, et al.
Cell Mol Life Sci
. 2025 Mar;
82(1):112.
PMID: 40074836
Background: Esophageal adenocarcinomas (EACs) represent an evolving tumor entity with high mortality rates. MET amplification is a recurrent driver in EACs and is associated with decreased patient survival. However, the...
2.
Wyzlic P, Damanakis A, Quaas A, Bruns C, Schmidt T
Chirurgie (Heidelb)
. 2025 Mar;
PMID: 40063096
Frozen sections are performed in pancreatic surgery for three reasons: histopathological confirmation of previously unclear space-occupying lesions, determination of the extent of surgical resection in an operative exploration and for...
3.
Tschammer R, Buss L, Pozarowska E, Morales C, Senanayake S, Prieto M, et al.
J Phys Chem C Nanomater Interfaces
. 2025 Feb;
129(7):3583-3594.
PMID: 40008200
Inverse oxide-metal model catalysts can show superior activity and selectivity compared with the traditional supported metal-oxide architecture, commonly attributed to the synergistic overlayer-support interaction. We have investigated the growth and...
4.
Rompen I, Yilmazcelik B, Crnovrsanin N, Schiefer S, Jorek N, Kantowski M, et al.
Dis Esophagus
. 2025 Feb;
38(1).
PMID: 39981709
Early delayed gastric conduit emptying (DGCE) is a frequent complication after Ivor-Lewis esophagectomy (ILE). Despite its relevance, few studies are published using the international consensus criteria. Therefore, we aimed to...
5.
Schmidt T, Stadnytskyi V
Appl Magn Reson
. 2025 Jan;
56(1-2):91-102.
PMID: 39886048
Supplementary Information: The online version contains supplementary material available at 10.1007/s00723-024-01720-5.
6.
Aghamaliyev U, Karimbayli J, Zamparas A, Bosch F, Thomas M, Schmidt T, et al.
Int J Surg
. 2025 Jan;
111(3):2376-2384.
PMID: 39878073
Objectives: Every year, around 300 million surgeries are conducted worldwide, with an estimated 4.2 million deaths occurring within 30 days after surgery. Adequate patient education is crucial, but often falls...
7.
Schiefer S, Crnovrsanin N, Rompen I, Jorek N, Al-Saeedi M, Schmidt T, et al.
J Cancer Res Clin Oncol
. 2025 Jan;
151(2):51.
PMID: 39875671
Purpose: Oncological esophagectomy is the mainstay in esophageal cancer treatment, but perioperative mortality remains a significant concern. Various scoring systems exist to identify patients at high risk for postoperative complications...
8.
Shigapov R, Schmidt T, Kamlah J, Schumm I, Streb J, Lehmann-Hasemeyer S
Data Brief
. 2025 Jan;
58():111238.
PMID: 39830614
The MaschinenBauIndustrie Knowledge Graph (MBI-KG) is a structured and semantically enriched dataset extracted from the 1937 publication "Die Maschinen-Industrie im Deutschen Reich" (The Machinery Industry in the German Reich), published...
9.
Krauss D, Schmidt T, Bruns C, Fuchs H
Chirurgie (Heidelb)
. 2025 Jan;
PMID: 39820665
The prognosis for esophageal cancer is determined in particular by the depth of infiltration (T stage) and lymph node metastasis (N status). In patients with locally advanced tumors, surgical resection...
10.
Szalai V, Bergonzo C, Lyon R, Lyon R, Kelman Z, Schmidt T, et al.
ChemMedChem
. 2025 Jan;
e202400917.
PMID: 39804085
Antibody-based pharmaceuticals are the leading biologic drug platform (> $75B/year). Despite a wealth of information collected on them, there is still a lack of knowledge on their inter-domain structural distributions,...